<![CDATA[Hepatitis B Initiative of Washington, D.C. - Press Releases]]>Mon, 30 Nov 2015 16:56:18 -0800EditMySite<![CDATA[World Hepatitis Day Award]]>Fri, 01 Aug 2014 14:52:12 GMThttp://www.hbi-dc.org/press-releases/world-hepatitis-day-awardPicture
Jane Pan, Executive Director of Hepatitis B Initiative of Washington, D.C. (HBI-DC) was recognized for her advocacy on Wednesday, July 30th, 2014 at the Occidental in Washington, D.C. following World Hepatitis Day at the White House.
Jane continues to raise awareness and save lives by providing the community with free hepatitis B and C testings. Since October of 2009, she has provided Hepatitis B education to 9000+ people and screened over 5700 people where 6.4% tested positive for Hepatitis B. Since 2013, she has also provided Hepatitis C education for 900+ people and screened over 800 where 5% tested positive for Hepatitis C. Thanks to collaborations with the government, community and religious organizations, HBI-DC has been able to provide education, screenings and vaccinations to the Asian, Pacific Islander, African and Hispanic communities. Those who tested positive are linked to care and referred for further evaluation and treatment.
Jane reiterated the importance of collaboration to combat this fight against viral hepatitis in her acceptance speech.” We have work to do. Together we can make a difference!”
Hepatitis B Initiative of Washington, D.C. (HBI-DC) seeks to mobilize communities to prevent liver disease caused by hepatitis B and C among the underrepresented communities. Our goal is to educate the population about viral hepatitis and empower the community with the resources to eradicate the disease. We provide resources that are culturally and linguistically appropriate for each community.

Corporate Hepatitis Alliance
The Corporate Hepatitis Alliance brings together experts in industry to play a more central role in advocating for increased access to quality health care and strengthening infrastructures for the diagnosis and care of people with Viral Hepatitis. Members include: AbbVie, Achillion Pharmaceuticals, Alere, Inc., Biotest Pharmaceuticals Corporation, Boehringer Ingelheim Pharmaceuticals, Bristol-Myers Squibb, Genentech, Gilead Sciences, Inc, GlaxoSmithKline, Health & Medicine Council of Washington, Johnson & Johnson, Kadmon Pharmaceuticals, Merck & Co., OraSure Technologies, Inc.

                                                                Educate, Empower and Eradicate

                                                                                                   # # #

<![CDATA[HBI-DC¬†Inducted New Members to the Leadership Circle and Honors Partners]]>Fri, 13 Jun 2014 03:07:18 GMThttp://www.hbi-dc.org/press-releases/hbi-dc-inducted-new-members-to-the-leadership-circle-and-honors-partnersOn Sunday, June 8, 2014, The Hepatitis B Initiative of DC (HBI-DC), a 501(c)3 non-profit organization that combats hepatitis B and C in at-risk communities, inducted Dr. Jose Bordon and Dr. Loc Le to the Leadership Circle and honored nine community partners with the Partnership Award.  The awardees included:

·         Mr. Dave Nguyen, Founder & Executive Coach, AASuccess

·         Ms. Elizabeth Bohle, Viral Hepatitis Prevention Coordinator, Maryland Department of Health & Mental Hygiene

·         Ms. Elizabeth Chung, Asian American Center of Frederick, MD (AACF)

·         Gia Long Alumnae Association

·         Dr. HeeSoon Juon, Associate Professor, Johns Hopkins Bloomberg School of Public Health

·         Mr. Jacob Mbafor, VFC Coordinator, District of Columbia Department of Health

·         Ms. Rita Lee, President, Chinese Consolidated Benevolent Association

·         Team HBV, Phi Delta Sigma, University of Maryland—College Park

·         Mr. William Hong, President, Korean-American Association of Virginia (KAVA)

The event took place at the China Garden Restaurant in Arlington, VA with over 260 attendees.  This is HBI-DC's 5th annual benefit gala and award dinner.

Ms. Kathy Parks, ABC 7 and News Channel 8 reporter and news anchor, was the Mistress of Ceremonies for the evening.

Mrs. Leslie Hsu Oh shared her personal story of why she founded HBI-DC after losing her brother and mother to liver cancer caused by hepatitis B.

Virginia Delegate Mark Keam presented Jane Pan, HBI-DC Executive Director, with House Joint Resolution 724, which passed in 2013, designating May 19th as Hepatitis B Awareness Day in Virginia.

Guest speaker, Ms. Julie Soohyun Koo, Executive Director of the D.C. Mayor's Office of Asian and Pacific Islander Affairs, provided opening remarks at the Gala.

Dr. Jennifer Lee, Deputy Secretary of Health and Human Resources of the Commonwealth of Virginia was a Keynote Speaker for the evening.

Ms. Corinna Dan, Viral Hepatitis Policy Advisor from the Office of the Assistant Secretary for Health, US Department of Health and Human Services, was a Keynote Speaker for the evening.

City Council Woman of the Town of Herndon, Grace Han Wolf, presented Jane Pan, HBI-DC Executive Director, with a Proclamation from Fairfax County Government declaring May as Hepatitis Awareness Month and May19th as Hepatitis Testing Day. 

Dr. Jose Bordon was inducted into the Leadership Circle by the Board of Directors. 

Dr. Loc Le was inducted into the Leadership Circle by the Board of Directors. 

About the Hepatitis B Initiative of DC (HBI-DC)

1 out of 10 Asian Americans are infected with Hepatitis B. Many do not know they are infected and can live without symptoms for many years until they develop liver cancer or liver failure. HBI-DC is a 501(c)3 nonprofit organization dedicated to preventing hepatitis B infection and its deadly consequences in at-risk groups through culturally and linguistically appropriate education, screening, vaccination and treatment referrals.

In the past year alone, HBI-DC provided education to 2,808 individuals; screenings for 2,232 individuals; vaccination for 189 high-risk individuals; and linked 96 hepatitis B positive individuals to care services, giving them a chance to prevent long-term complications of this disease.  This was done at no charge or very low cost to any participants.  All funds raised are used to support free hepatitis B education, screening, and vaccination events in the DC metro area.
To learn more and to support the work of HBI-DC, visit our website at http://www.hbi-dc.org.

For more information about the event, contact janepan@hbi-dc.org  or  571-274-0021


<![CDATA[National Viral Hepatitis Roundtable Honors Jane Pan with Community Advocate Award]]>Tue, 24 Sep 2013 16:50:38 GMThttp://www.hbi-dc.org/press-releases/national-viral-hepatitis-roundtable-honors-jane-pan-with-community-advocate-awardPicture
Jane Pan, Executive Director of Hepatitis B Initiative of Washington, D.C. (HBI-DC), received the Community Advocate Award at the National Viral Hepatitis Roundtable (NVHR) 10thAnniversary Gala on Thurs., Sept. 19 at the Omni Shoreham Hotel in Washington, D.C. She joined four other devoted health advocates as award recipients of the night.
As a community advocate, Ms. Pan continually demonstrates her passion for achieving health equity through her work with HBI-DC. Since 2008, Ms. Pan led HBI-DC to work with community partners and organizations to bring awareness, vaccinations and treatment of hepatitis B and C to underserved and at-risk populations.
“As public health advocates, we reach out to those who are underserved and unreached by traditional health care delivery,” Ms. Pan affirmed in her acceptance speech at the gala. “To navigate these challenges, collaboration is the key.”
With limited funds and staff, HBI-DC collaborates with numerous volunteers, doctors, health care providers, public health professionals and community- and faith-based organizations.
So far this year, HBI-DC provided education to over 2,000 people and screened over 1,750 individuals at health fairs and health screenings throughout the Washington, D.C. metro area. HBI-DC consistently found that six to 10% tested positive for hepatitis B while 26 to 32% are at-risk and need vaccinations. In two communities we found 4-5% tested positive with hepatitis C.
Hepatitis B Initiative of Washington, D.C. (HBI-DC) seeks to mobilize communities to prevent liver disease caused by hepatitis B among Asian Americans, Pacific Islanders, African newcomers, and other high-risk groups in the Washington, D.C. metropolitan area. Through collaborative partnerships, HBI-DC provides culturally and linguistically appropriate hepatitis B outreach, education, screening, vaccination, linkages to care, and patient navigation services for impacted communities.